You are here

Humira

Pfizer's Xeljanz drops off top June TV spenders list—and Gilead's Biktarvy fills the void

Fierce Pharma

Thu, 07/11/19 - 09:45 am

Gilead Sciences

Why AbbVie's Stock Sank in the First Half of 2019

Motley Fool

Fri, 07/5/19 - 01:51 pm

5 reasons AbbVie bought Allergan, and why they may not be enough

Biopharma Dive

Wed, 06/26/19 - 04:57 pm

diversification

AbbVie to acquire Allergan for $63 billion in megamerger of pharma giants

Stat

Tue, 06/25/19 - 09:18 am

Meet the Top Ten Drugs of 2024 (Maybe)

Drug Channels

Tue, 06/18/19 - 11:46 pm

Bristol-Myers Squibb

Lilly’s Taltz scrapes win against Humira in psoriatic arthritis

Pharmaforum

Fri, 06/14/19 - 06:22 pm

psoriatic arthritis

Iranian drugmaker opens $100M plant in Turkey, will make Humira biosimilar

Fierce Pharma

Thu, 06/13/19 - 09:50 pm

CinnaGen Pharmaceuticals

Look here, FDA: Eli Lilly touts Olumiant safety data for unapproved high dose

Fierce Pharma

Wed, 06/12/19 - 06:43 pm

rheumatoid arthritis

AbbVie's discounting Humira to aid Skyrizi's launch—and a price war could follow: analyst

Fierce Pharma

Mon, 05/20/19 - 11:07 pm

AbbVie stock up 1.3% after announcing resolution to litigation over Humira in the U.S.

Marketwatch

Tue, 05/14/19 - 09:31 am

Boehringer Ingelheim

Biosimilar competition to AbbVie’s Humira is eroding profits, but company says it has confidence in pipeline

Marketwatch

Sun, 04/28/19 - 12:16 pm

Say goodbye to AbbVie's ever-growing Humira sales: The biosim decline has officially begun

Fierce Pharma

Thu, 04/25/19 - 07:16 pm

What You Need to Know About AbbVie's Surprisingly Strong Q1 Earnings

Motley Fool

Thu, 04/25/19 - 07:15 pm

AbbVie successor to Humira in psoriasis gains FDA approval

BioCentury

Tue, 04/23/19 - 10:59 pm

AbbVie shareholder joins the growing ranks of critics, calling for an independent chairman

Endpoints

Wed, 04/3/19 - 12:50 pm

Richard Gonzalez

AbbVie's massive Humira discounts are stifling Netherlands biosimilars: report

Fierce Pharma

Tue, 04/2/19 - 12:09 pm

AbbVie faces class action lawsuit from New York grocery union over Humira 'patent thicket'

Fierce Pharma

Wed, 03/20/19 - 08:06 pm

2 Things Investors Are Missing About AbbVie

Motley Fool

Sun, 03/17/19 - 01:29 pm

AbbVie’s Humira Remains the Top-Selling Prescription for 2018

Biopharma Dive

Wed, 03/13/19 - 01:02 pm

prescription data

Takeda’s Entyvio Bests Humira in Head-to-Head UC Study

BioSpace

Mon, 03/11/19 - 10:25 am

ulcerative colitis

Pages